ALLISON DOUGLAS-CLEMENTS: Open Payments
NPI 1649391418 · MIDLOTHIAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,818 in 96 payments from 15 companies in 2025. Trend: 2023 $1,927 · 2024 $1,483 · 2025 $1,818
Food & beverage: $1,818
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $464 |
| Neurocrine BioSciences, Inc. | 11 | $246 |
| Otsuka America Pharmaceutical, Inc. | 10 | $236 |
| ABBVIE INC. | 20 | $232 |
| Vanda Pharmaceuticals Inc. | 11 | $141 |
| Lundbeck LLC | 3 | $80 |
| Alkermes, Inc. | 3 | $73 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Janssen Biotech, Inc. | 3 | $55 |
Products named: CAPLYTA, REXULTI, INGREZZA, VRAYLAR, FANAPT, ARISTADA, TRINTELLIX, TREMFYA.
Industry payments across VA — which companies pay providers there.
